New program aims to protect liver patients from dangerous painkiller side effects during surgery
NCT ID NCT07249294
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a hospital program to avoid giving NSAIDs or metamizole to people with advanced chronic liver disease who need major surgery. These painkillers are risky for them because they can cause kidney damage, fluid buildup, or bleeding. The program will track how often these drugs are prescribed and whether it reduces complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CHRONIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital del Mar
Barcelona, 08003, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking hospital care for liver patients reduce repeat admissions?
- New ultrasound technique could replace needle biopsy for liver patients
- Could a simple ultrasound replace liver biopsies for this rare disease?
- Computer-Guided statin dosing shows promise for liver patients
- Liver clot study seeks to predict recovery in 1,500 patients
- No-Needle liver check: spleen scan may spot silent danger